Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Newco with NASH treatment gets finance

Country: Netherlands

NorthSea Therapeutics BV, a Dutch company established in November 2017 to exploit a licence for a NASH treatment called Icosabutate, has raised €25 million in a series-A equity financing that will allow NorthSea to run a critical phase 2b, proof-of-concept study of the drug by the end of 2018.

Read more

LSP raises €280 million for healthcare innovation fund

Country: Netherlands

Netherlands-based LSP (Life Sciences Partners) has raised €280 million in the first and final closing of a new medical technology fund that will invest in companies developing medical devices, diagnostics and applications for digital health. 

Read more

FDA approves first follow-on diabetes drug

Country: United States

Read more

Hookipa raises €50 million for vaccine development

Country: Austria

Read more

Series A funding for Belgian start-up

Country: Belgium

Read more

OSE Immunotherapeutics' trial to reopen

Country: France

Read more

Medigene raises forecast after sale of asset

Country: Germany

Read more

GW Pharma to float US shares

Country: United Kingdom

Read more

GW Pharma annual operating loss soars

Country: United Kingdom

Read more

Semma raises $114 million for diabetes project

Country: United States

Read more

MorphoSys increases financial guidance

Country: Germany

Read more

Siemens plans to list diagnostics business

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

The case for value-based pricing by Tara Raveendran

Value-basedpricingTaraRaveendranNovDec2017.pdf

Highlights of the November-December 2017 MedNous issue

The November-December 2017 MedNous features:

Latest Mednous cover
  • Business Strategy
    Europe’s biotech entrepreneurs
  • Public Policy
    The case for value-based pricing
    By Tara Raveendran
  • Research Strategy
    Bill Gates backs Alzheimer’s disease research
    By Jean-Claude Muller
  • Oncology Review
    The rise of single-arm studies
    By Bruno Pagliara
  • Corporate Strategy
    Priorities of the new Novartis CEO
    By Robin Davison
  • Regenerative Medicine
    Commercialising CAR T cell therapies
    By Ravi Nalliah

The latest MedNous journal. Subscribe to download.